11C-acetate PET for Multiple sclerosis

11C-acetate PET for Multiple sclerosis - 11C-acetate PET for Multiple sclerosis

Status

Recruiting

Phases

Unknown

Study type

Interventional

Source

JPRN

Registry ID

JPRN-UMIN000018154

Enrollment

Registered

2015-07-01

Start date

2015-07-01

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Multiple Sclerosis, NMO

Interventions

Withdraw blood before and after the injection of 11C-acetate

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: 20 MS patients who go to department of Neurology of Osaka University Hospital and 10 healthy subjects

Exclusion criteria

Exclusion criteria: Woman who is pregnant or breast-feeding

Design outcomes

Primary

Measure	Time frame
Time to reach maximam concentration of radioactivity in brain	—

Secondary

Measure	Time frame
Time to reach maximam concentration of radioactivity in blood	—

Countries

Japan

Contacts

Public ContactYuji Nakatsuji

Osaka University Neurology

yuji@neurol.med.osaka-u.ac.jp06-6879-3571

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026